Febrile Neutropenia

• EMA withdrawal · 2025-06-04
  EMA Application withdrawn: Pelgraz Paediatric (pegfilgrastim) — Accord Healthcare S.L.U.

  The EMA has withdrawn the application for Pelgraz Paediatric (pegfilgrastim) submitted by Accord Healthcare S.L.U., in the therapeutic areas…

• CLINICAL_TRIALS withdrawal · 2024-09-19
  Clinical Trial Update: Antimicrobial Revision in Persistent Febrile Neutropenia [Phase 4]

  A Phase 4 clinical trial evaluating an antimicrobial revision for persistent febrile neutropenia has been withdrawn.

• CLINICAL_TRIALS withdrawal · 2022-03-31
  Clinical Trial Update: Amoxicillin-clavulanate Alone or in Combination With Ciprofloxacin in Low-Risk Febrile Neutropenic Adult Patients: A Prospective, Double-blind, Randomized, Non-Inferiority Multicenter, Phase III Clinical Trial. [Phase 3]

  Phase III trial evaluating amoxicillin-clavulanate alone or with ciprofloxacin in low-risk febrile neutropenia; study status withdrawn.

• CLINICAL_TRIALS withdrawal · 2019-02-01
  Clinical Trial Update: Early Stoppage Versus Continuation of Antimicrobial Therapy in Low Risk Pediatric Cancer Patients With Febrile Neutropenia, Before Recovery of Counts: -DALFEN Study [Phase 3]

  A Phase 3 trial evaluating early stoppage versus continuation of antimicrobial therapy in low-risk pediatric cancer patients with febrile ne…

• CLINICAL_TRIALS withdrawal · 2013-06-07
  Clinical Trial Update: Short-term Antibiotic Treatment for Unexplained Fever in Solid Cancer Patients With Febrile Neutropenia [NA]

  This clinical trial update reports that the study evaluating short-term antibiotic treatment for unexplained fever in solid cancer patients …

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.